Week in Review
Acceleron Pharma Inc. has filed for an initial public offering (IPO) that aims to raise about $74.7 million.
Apexigen Inc. raised $20 million in a Series A1 financing to advance its cancer therapy, APX005.
Engene Inc. completed an initial closing of a $13.25 million financing led by Lumira Capital.
Intrexon Corp. priced its IPO of about 10 million shares at $16 apiece.
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-770-810-3144
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter